TILIZATION OF MEDICALimaging has grown rapidly in recent years. 1 Along with the benefits patients have received from medical imaging has come an increase in the burden of ionizing radiation associated with many such tests and the attendant potential risks of cancer. The National Council on Radiation Protection and Measurements has estimated that the per capita dose of medical radiation in the United States increased nearly 6-fold from the early 1980s to 2006. 2 This increased medical radiation burden has raised public health concerns, leading to a US Food and Drug Administration initiative to reduce unnecessary radiation exposure from medical imaging, 3 with one of its focuses being nuclear imaging, and discussion in Congress of new legislation to regulate medical radiation. 4 Although much attention has been paid to radiation from computed tomography (CT) scans, 5,6 a recent study demonstrated that the single test with the highest radiation burden, accounting for 22% of cumulative effective dose from medical sources, is myocardial perfusion imaging (MPI). 7 Volume of MPI increased from less than 3 million procedures in the United States in 1990 to 9.3 million in 2002, 8 and it is now estimated to account for more than 10% of the entire cumulative effective dose to the US population from all sources, excluding radiotherapy. 2